EPA Form 8570-35 Data Matrix

Form Approved OMB Nos. 2070-0060; 2070-0174

U N ITED STA TES EN VIR O N M EN TA L PR O TEC TIO N A G EN C Y
1200 Pennsylvania A venue,N .W .
W A SH IN G TO N ,D .C . 20460
Paperwork Reduction Act Notice: This collection of information is approved by OMB under the Paperwork Reduction Act, 44 U.S.C. 3501 et seq. (OMB Control No. 2070-0060). Responses to this collection of
information are mandatory (40 CFR 158). An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The
public reporting burden for this collection of information is estimated to average 0.25 hours per response for registration and 0.25 hours per response for reregistration and special review activities. Send comments on
the Agency's need for this information, the accuracy of the provided burden estimates and any suggested methods for minimizing respondent burden to the Regulatory Support Division Director, U.S. Environmental
Protection Agency (2821T), 1200 Pennsylvania Avenue, N.W., Washington, DC 20460. Include the OMB control number in any correspondence. Do not send the completed form to this address.

D A TA M A TR IX
Date

EPA Reg No./File Symbol

Applicant’s/Registrant’s Name & Address

Product

Page

Ingredient
Guideline Reference Number

Guideline Study Name

Signature

EPA Form 8570-35 (12-2003) Electronic and Paper versions available. Submit only Paper version.

MRID Number

Submitter

Name and Title

Status

Note

Date

A gency InternalU se C opy

of

U N ITED STA TES EN VIR O N M EN TA L PR O TEC TIO N A G EN C Y
1200 Pennsylvania A venue,N .W .
W A SH IN G TO N ,D .C . 20460

Form Approved OMB Nos. 2070-0060; 2070-0057;
2070-0107; 2070-0122; 2070-0164

Paperw ork R eduction A ctN otice: The public reporting burden for this collection of information is estimated to average 0.25 hours per response for registration activities and 0.25 hours per response for
reregistration and special review activities, including time for reading the instructions and completing the necessary forms. Send comments regarding the burden estimate or any other aspect of this collection of
information, including suggestions for reducing the burden to: Director, Collection Strategies Division (2822T), U.S. Environmental Protection Agency, 1200 Pennsylvania Avenue, N.W., Washington, DC 20460.
Do not send the form to this address.

D A TA M A TR IX
Date

EPA Reg No./File Symbol

Applicant’s/Registrant’s Name & Address

Product

Page

Ingredient
Guideline Reference Number

Guideline Study Name

Signature

EPA Form 8570-35 (12-2003) Electronic and Paper versions available. Submit only Paper version.

MRID Number

Submitter

Status

Name and Title

Note

Date

Public File C opy

of

IN STR U C TIO N S FO R D A TA M A TR IX

IN STR U C TIO N S: Identify all data submitted or cited and all submitters from whom permission has been received or to whom offers to pay have been sent by entering sufficient information in the attached
matrix (photocopy and attach additional pages as necessary). Complete all columns; omission of essential information will delay approval of the registration/reregistration. On each page enter the date,
Applicant's/Registrant's name, EPA Registration Number or application file symbol of the product, ingredient, page number, and total number of pages.
The Data Compensation Form entitled "Certification with Respect to Citation of Data" and the Data Matrix will be publicly available, except for the Guideline Reference Number, Guideline Study Name, and
MRID Number columns after the registration/reregistration of this product has been granted or once this form is received in response to a Data-Call-In Notice. However, the information in the Guideline
Reference Number, Guideline Study Name, and MRID Number columns is available through the Freedom of Information Act in association with the EPA Registration Number.
Ingredient: Identify the active ingredient(s) in this product for which data are cited. The active ingredient(s) are to be identified by entering the chemical name and the CAS registry number. Begin a new
page for each separate active ingredient for which data are cited. If bridging data from a related chemical or representative test compound are cited, enter the identity of that chemical/representative test
compound including the EPA Registration Number/File Symbol if appropriate.
If the cite-all method is used for all data supporting this particular ingredient, enter "CITE-ALL" in the Guideline Reference Number column and leave the Guideline Study Name column blank. If
the cite-all method is used for a particular Guideline Reference Number enter "CITE-ALL" in the MRID Number column on the line for that Guideline Reference Number. In either case, enter all submitters
to whom offers to pay have been sent on subsequent lines. [Note: if the selective method of support is used and written authorization (letter of permission) is provided, the individual Guideline Reference
Number, Guideline Study Name, and MRID Number columns must still be completed.] Otherwise:
G uideline R eference N um ber: Enter on separate lines in numerical order the Guideline Reference Numbers from 40 CFR Part 158 for all studies cited to support the registration/reregistration for this
ingredient.
G uideline Study N am e: For each Guideline Reference Number cited, enter the corresponding Guideline Study Name.
M R ID N um ber: For each individual study cited in support of a Guideline Reference Number and Guideline Study Name, enter the Master Record Identification (MRID) Number listed in the Pesticide
Document Management System (PDMS). Enter only one MRID Number on each line. Note that more than one MRID Number may be required per Guideline Reference Number. Note: Occasionally a
study required to maintain a registration/reregistration is not associated with a Guideline Reference Number and Guideline Study Name. In such case, enter the MRID Number(s) for the study(ies).
Subm itter: Using the most recent Data Submitters List, identify the Original Data Submitter with their current address for each study cited. The EPA assigned company number or other abbreviation may
be used. Clearly explain any variations (alternate addresses, data owners not on the Data Submitters List, etc.) in footnotes to this table.
Status: Enter one of the following codes for each study cited, as appropriate:
OWN:

I am the Original Data Submitter for this study.

EXC:

I have obtained written permission of the Original Data Submitter to cite this exclusive-use study in support of this application.

PER:

I have obtained the permission of the Original Data Submitter to use this study in support of this application.

OLD:

The study was submitted more than 15 years ago and all periods of compensation have expired.

PL:

The study is in the public literature.

PAY:

I have notified in writing the Original Data Submitter or, if the cite-all method is used, all companies listed in the most current Data Submitters List for this ingredient, and have offered
(a) to pay compensation in accordance with FIFRA sections 3(c)(1)(F) and/or 3(c)(2)(B), and (b) to commence negotiations to determine the amount and terms of compensation, if any,
to be paid for the use of the study(ies).

GAP:

This Guideline data requirement is a data gap as defined in 40 CFR sections 152.83(a) and 152.96.

FOR:

I am taking the formulator's exemption for this ingredient only. Other columns of this line should be marked "NA". However, if this product is to be registered/reregistered for additional
uses for which the purchased EPA registered ingredient is not supported, additional data must be submitted or cited here to support those uses.

Note:

If additional explanation is needed, enter a footnote number in this column and attach the corresponding explanation.